AstraZeneca's new pill has demonstrated significant effectiveness in lowering blood pressure in patients who struggle with conventional treatments, according to results from a late-stage clinical trial. The trial showed that the pill not only met its primary endpoint but also improved patient outcomes significantly. This development could offer a new therapeutic option for those with hard-to-treat hypertension.